Influence of Statins on Influenza Vaccine Response in Elderly Individuals

Journal of Infectious Diseases

Volumn 213, Issue 8, 2016, Pages 1224-1228

  Black, Steven ^a   Nicolay, Uwe ^b   Del Giudice, Giuseppe ^c   Rappuoli, Rino ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Novartis Vaccine   (Germany)

^c NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

elderly; immunogenicity; influenza vaccine; statins

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; MEVINOLIN; MIFAMURTIDE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS STRAIN; VIRUS TITRATION; BLOOD; DRUG INTERACTION; IMMUNOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLUENZA VACCINES; MALE; MIDDLE AGED;

EID: 84965178537     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv456     Document Type: Article

References (17)

1. Lewington S, Whitlock G, Clarke R, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007; 370:1829-39.
2. Ioannidis JA. More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines. JAMA 2014; 311:463-4.
3. Weitz-Schmidt G, Welzenbach K, Brinkmann V, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 2001; 7:687-92.
4. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005; 4:977-87.
5. ThompsonWW, Shay DK,Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
6. Frey SE, Aplasca-De Los Reyes MR, Reynales H, et al. Comparison of the Safety and Immunogenicity of an MF-59 adjuvanted with a Non-adjuvanted seasonal influenza vaccine in Elderly Subjects. Vaccine 2014; 32:5027-34.
7. Stephenson I, Nicholson KG, Gluck R, et al. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet 2003; 362:1959-66.
8. Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD. Healthy life expectancy in 191 countries, 1999. Lancet 2001; 357:1685-91.
9. Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008; 86:140-6.
10. Packard RS, Schlegel S, Senouf D, et al. Atorvastin treatment and vaccination efficacy. J Clin Pharmacol 2007; 47:1022-7.
11. Lee PY, Sumpia PO, Byars JA, et al. Short-term atorvastin treatment enhances specific antibody production following tetanus toxoid vaccination in healthy volunteers. Vaccine 2006; 24:4035-40.
12. Monto AS, Hornbuckle K, Ohmit SE. Influenza vaccine effectiveness among elderly nursing home residents: A cohort study. Am J Epidemiol 2001; 154:155-60.
13. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. the efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27.
14. Young R, Hopkins RJ. Statin use in pneumonia. Am J Med 2011; 126:e11-2.
15. Yende S, Milbrandt EB, Kellum JA, et al. Understanding the potential role of statins in pneumonia and sepsis. Crit Care Med 2011; 39:1871-8.
16. Fedson DS. Treating influenza with statins and other immunomodulatory agents. Antiviral Res 2013; 99:417-35.
17. Fedson DS. How will physicians respond to the next influenza pandemic? Clin Infect Dis 2014; 58:233-7.